| Literature DB >> 31038857 |
Victor Srougi1, João A B Barbosa1, Isaac Massaud1, Isadora P Cavalcante2, Fabio Y Tanno1, Madson Q Almeida2, Miguel Srougi1, Maria C Fragoso2, José L Chambô1.
Abstract
PURPOSE: To investigate risk factors for complications in patients undergoing adrenalectomy.Entities:
Keywords: Adrenalectomy; Morbidity; Pathology
Mesh:
Year: 2019 PMID: 31038857 PMCID: PMC6786121 DOI: 10.1590/S1677-5538.IBJU.2018.0482
Source DB: PubMed Journal: Int Braz J Urol ISSN: 1677-5538 Impact factor: 1.541
Pre-operative preparation.
| Adrenal disease | Preparation |
|---|---|
| Hiperaldosteronism | Oral Spironolactone when K <3.5 and BP >140×90 mmHg |
| Pheocromocytoma | Oral Prazosin until mean BP is between 65-90 mmHg |
| ACC | Sub-cutaneous Enoxaparin until 12h before surgery Meningococcal, Pneumococcal and |
| Cortisol producing adenoma, Cushing's disease and PMAH | Sub-cutaneous Enoxaparin until 12h before surgery, 100 mg of intra-venous Hydrocortisone in anesthetic induction. |
BP = blood pressure; PMAH = primary macronodular adrenal hyperplasia; ACC = adrenocortical carcinoma.
Final pathology of large adrenal masses suspect of adrenocortical carcinoma at diagnosis (N=25).
| Final Pathology | N (%) |
|---|---|
| ACC | 11 (44%) |
| Adenoma | 7 (28%) |
| Mielolipoma | 2 (8%) |
| Hemangioma | 2 (8%) |
| Ganglioneuroma | 1 (4%) |
| Schwanoma | 1 (4%) |
|
| 1 (4%) |
ACC = adrenocortical carcinoma
Demographic and clinical presentation characteristics.
| Parameters | Mean ± SD | Median (IQR) | |
|---|---|---|---|
| Age (years) | 50.8±14.9 | 52 (40-62) | |
| Sex, males | 52 (33.8%) | ||
|
| |||
| Right (%) | 64 (41.5%) | ||
| Left (%) | 62 (40.3%) | ||
| Bilateral (%) | 28 (18.2%) | ||
| BMI (kg/m2) | 29.2±6.7 | 27.8 (25-33) | |
|
| |||
| 0 | 48 (31.2%) | ||
| 1-5 | 89 (57.8%) | ||
| 5-10 | 15 (9.7%) | ||
| >10 | 2 (1.3%) | ||
|
| |||
| Incidental | 31 (20.1%) | ||
| Blood hypertension | 68 (44.2%) | ||
| Cushing syndrome | 29 (18.8%) | ||
| Hypertensive crisis | 17 (11%) | ||
| Pain | 13 (8.4%) | ||
| Palpable mass | 8 (5.2% | ||
| Virilization | 5 (3.2%) | ||
|
| |||
| Aldosterone producing adenoma | 39 (25.3%) | ||
| Pheocromocytoma | 33 (21.4%) | ||
| PMAH | 16 (10.5%) | ||
| Cortisol producing adenoma | 15 (9.7%) | ||
| Cushing's disease | 15 (9.7%) | ||
| ACC | 25 (16.2%) | ||
| Paraganglioma | 4 (2.6%) | ||
| Myelolipoma | 2 (1.3%) | ||
| Metastasis | 2 (1.3%) | ||
| Cyst | 2 (1.3%) | ||
| Ganglioneuroma | 1 (0.7%) | ||
| Tumor size, (cm) | 4.9±4 | 3.4 (2-6.5) | |
BMI = body mass index; PMAH = primary macronodular adrenal hyperplasia, ACC = adrenocortical carcinoma.
Demographic and clinical presentation characteristics.
| Parameters | Mean ± SD | Median (IQR) | |
|---|---|---|---|
|
| |||
| Adenoma | 59 (38.3%) | ||
| Pheocromocytoma | 36 (23.4%) | ||
| PMAH | 18 (11.7%) | ||
| ACC | 11 (7.1%) | ||
| Other | 30 (19.5%) | ||
|
| |||
| Laparoscopic | 123 (79.9%) | ||
| Open | 25 (16.2%) | ||
| Converted | 6 (4.9%) | ||
|
| |||
| Unilateral total | 126 | ||
| Bilateral total | 7 | ||
| Bilateral partial / total | 21 | ||
| Surgery duration (min) | 154±59 | 140 (120-180) | |
| Estimated blood loss (mL) | 139±224 | 50 (50-100) | |
| Blood transfusion | 7 (4.5%) | ||
| Intra-operative hemodynamic instability | 29 (18.8%) | ||
|
|
| ||
| Satava 1 | 15 (9,7%) | ||
| Satava 2 | 1 (0,6%) | ||
| Satava 3 | 0 | ||
|
|
| ||
| Clavien 1-2 | 27 (17,5%) | ||
| Clavien 3a | 6 (3,9%) | ||
| Clavien 3b | 3 (1,9%) | ||
| Clavien 4 | 0 | ||
| Clavien 5 | 4 (2,6%) | ||
|
|
| 4 (3-8) | |
BMI = body mass index; PMAH = primary macronodular adrenal hyperplasia; ACC = adrenocortical carcinoma.
Post-operative major complications (N = 13).
| Clavien classification | N | |
|---|---|---|
|
| ||
| Sepsis (respiratory) | 1 | |
| Pulmonary thromboembolism | 1 | |
| Cardiac stroke | 2 | |
| Cardiac arrhythmia | 2 | |
|
| ||
| Infected retroperitoneal hematoma | 2 | |
| Retroperitoneal hematoma with need of hemostasis | 1 | |
|
| ||
| Septic complications | 2 | |
| Pulmonary thromboembolism | 1 | |
| Cardiac arrest | 1 | |
Exposed with details in table 6.
Cause of death (N=4).
| # | Final pathology | Age (years) | Charlson score | Surgical access | Tumor size (cm) | Cause of death |
|---|---|---|---|---|---|---|
| 1 | ACC | 86 | 6 | Open | 8.4 | Septic shock due to pneumonie |
| 2 | ACC M+ | 42 | 8 | Open | 11.3 | Septic shock after evisceration |
| 3 | ACC M+ | 55 | 9 | Open | 17.5 | Cardiac arrest after severe hemodinamic instability |
| 4 | Adenoma | 67 | 4 | Lap | 2.5 | Pulmonary thromboembolism |
ACC = Adrenocortical carcinoma; M+ = Metastatic; Lap = Laparoscopic
Results stratified by laparoscopic, open and converted surgery.
| Laparoscopic | Open | Converted | |
|---|---|---|---|
| Cases | 123 (79.9%) | 25 (16.2%) | 6 (4.9%) |
| Bilateral n(%) | 25 (20.3%) | 2 (8%) | 2 (33%) |
| Reintervention n (%) | 3 (2.4%) | 2 (8%) | 1 (16%) |
| Pathologoy | |||
| Pheocromocytoma | 32 | 2 | 2 |
| Adenoma | 56 | 2 | 1 |
| PMAH | 16 | 2 | 0 |
| ACC | 1 | 10 | 0 |
| Other | 18 | 9 | 3 |
| Estimated blood loss (Mean ± SD) | 91.2mL (± 164.8) | 350mL (±374.6) | 366.7mL (±206.6) |
| Surgery duration in minutes (Mean ± SD) | 143.6 (±49.6) | 208 (±80.4) | 183 (±20.7) |
| Blood transfusion | 0 | 6 (24%) | 1 (16%) |
| Clavien Major (>2) | 6 (4.8%) | 6 (24%) | 1 (16%) |
| Hospitalization duration in days (Median, range) | 4 (2-38) | 4 (1-17) | 10.5 (3-17) |